good-To The Moon - Tiger Brokers Online Investing Community - To The Moon

Like
Comment
Favorite

真正的Man
2023-08-10

good

宝沙发展(01069.HK)与深圳佳仕森就拟发展人参品种及等级、种植及加工方法及预期时间表进行讨论

来源：格隆汇格隆汇8月10日丨宝沙发展公告，有关公司与深圳佳仕森投资(集团)有限公司就发展人参业务战略合作。于会议期间，公司进一步了解深圳佳仕森于西洋参市场的能力以证实合作计划。于会议期间，公司管理层与深圳佳仕森就拟发展的人参品种及等级、种植及加工方法以及该业务发展的预期时间表进行讨论。西洋参的品质将由经认证实验室定期进行检测，且生产线将适时进行微调以确保所生产的西洋参等级达到标准。

宝沙发展(01069.HK)与深圳佳仕森就拟发展人参品种及等级、种植及加工方法及预期时间表进行讨论

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Like

Report

Comment

Top
Latest

empty

No comments yet

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":207478225756224,"tweetId":"207478225756224","gmtCreate":1691682511290,"gmtModify":1691682562448,"author":{"id":4148125164614992,"idStr":"4148125164614992","authorId":4148125164614992,"authorIdStr":"4148125164614992","name":"真正的Man","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>good</p></body></html>","htmlText":"<html><head></head><body><p>good</p></body></html>","text":"good","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/207478225756224","repostId":2358722680,"repostType":2,"repost":{"id":"2358722680","kind":"highlight","pubTimestamp":1691675960,"share":"https://www.laohu8.com/m/news/2358722680?lang=&edition=full","pubTime":"2023-08-10 21:59","market":"hk","language":"zh","title":"宝沙发展(01069.HK)与深圳佳仕森就拟发展人参品种及等级、种植及加工方法及预期时间表进行讨论","url":"https://stock-news.laohu8.com/highlight/detail?id=2358722680","media":"市场资讯","summary":"来源：格隆汇格隆汇8月10日丨宝沙发展公告，有关公司与深圳佳仕森投资(集团)有限公司就发展人参业务战略合作。于会议期间，公司进一步了解深圳佳仕森于西洋参市场的能力以证实合作计划。于会议期间，公司管理层与深圳佳仕森就拟发展的人参品种及等级、种植及加工方法以及该业务发展的预期时间表进行讨论。西洋参的品质将由经认证实验室定期进行检测，且生产线将适时进行微调以确保所生产的西洋参等级达到标准。","content":"<html><body><div>\n<p>来源：格隆汇</p><p cms-style=\"font-L\">格隆汇8月10日丨<font cms-style=\"font-L\"><span><a href=\"https://laohu8.com/S/01069\">宝沙发展</a></span><span></span>(01069.HK)公告，</font><font cms-style=\"font-L\">有关公司与深圳佳仕森投资(集团)有限公司(\"深圳佳仕森\")就发展人参业务战略合作。</font></p><p cms-style=\"font-L\">订立战略合作协议后，公司管理层与深圳佳仕森已举行会议以进一步讨论该业务发展详情。于会议期间，公司进一步了解深圳佳仕森于西洋参市场的能力以证实合作计划。深圳佳仕森专注于陕西省从事西洋参的种植、研发、加工及销售。其拥有西洋参开发的完整生产线并与多所高校建立广泛的西洋参研发网络。</p><p cms-style=\"font-L\">于会议期间，公司管理层与深圳佳仕森就拟发展的人参品种及等级、种植及加工方法以及该业务发展的预期时间表进行讨论。双方拟就该业务项下将生产的西洋参共同建立品牌，并拟于2023年最后一个季度开始该业务试运营。试运营期间，双方将建立一条生产线。西洋参的品质将由经认证实验室定期进行检测，且生产线将适时进行微调以确保所生产的西洋参等级达到标准。所进行检测将主要专注西洋参有效成分的水平，特别是人参皂苷、精油、微量元素及多糖。</p><p cms-style=\"font-L\">一旦生产线完全建成，能生产稳定品质及数量的西洋参以供消费后，双方亦可考虑利用西洋参开发其他保健品及副产品，如中草药饮料、人参酒、护肤品及化妆品。</p>\n<div>\n<span>现在送您60元福利红包，直接提现不套路~~~快来参与活动吧！</span>\n<img src=\"\"/>\n</div>\n<div>\n<div><img src=\"\"/></div>\n<div>海量资讯、精准解读，尽在新浪财经APP</div>\n</div>\n</div></body></html>","source":"highlight_sina","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>宝沙发展(01069.HK)与深圳佳仕森就拟发展人参品种及等级、种植及加工方法及预期时间表进行讨论</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n宝沙发展(01069.HK)与深圳佳仕森就拟发展人参品种及等级、种植及加工方法及预期时间表进行讨论\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-08-10 21:59 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-08-10/doc-imzftrur6509887.shtml><strong>市场资讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>来源：格隆汇格隆汇8月10日丨宝沙发展(01069.HK)公告，有关公司与深圳佳仕森投资(集团)有限公司(\"深圳佳仕森\")就发展人参业务战略合作。订立战略合作协议后，公司管理层与深圳佳仕森已举行会议以进一步讨论该业务发展详情。于会议期间，公司进一步了解深圳佳仕森于西洋参市场的能力以证实合作计划。深圳佳仕森专注于陕西省从事西洋参的种植、研发、加工及销售。其拥有西洋参开发的完整生产线并与多所高校建立...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-08-10/doc-imzftrur6509887.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"01069":"中国健康科技集团","BK1210":"林业产品"},"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-08-10/doc-imzftrur6509887.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","article_id":"2358722680","content_text":"来源：格隆汇格隆汇8月10日丨宝沙发展(01069.HK)公告，有关公司与深圳佳仕森投资(集团)有限公司(\"深圳佳仕森\")就发展人参业务战略合作。订立战略合作协议后，公司管理层与深圳佳仕森已举行会议以进一步讨论该业务发展详情。于会议期间，公司进一步了解深圳佳仕森于西洋参市场的能力以证实合作计划。深圳佳仕森专注于陕西省从事西洋参的种植、研发、加工及销售。其拥有西洋参开发的完整生产线并与多所高校建立广泛的西洋参研发网络。于会议期间，公司管理层与深圳佳仕森就拟发展的人参品种及等级、种植及加工方法以及该业务发展的预期时间表进行讨论。双方拟就该业务项下将生产的西洋参共同建立品牌，并拟于2023年最后一个季度开始该业务试运营。试运营期间，双方将建立一条生产线。西洋参的品质将由经认证实验室定期进行检测，且生产线将适时进行微调以确保所生产的西洋参等级达到标准。所进行检测将主要专注西洋参有效成分的水平，特别是人参皂苷、精油、微量元素及多糖。一旦生产线完全建成，能生产稳定品质及数量的西洋参以供消费后，双方亦可考虑利用西洋参开发其他保健品及副产品，如中草药饮料、人参酒、护肤品及化妆品。\n\n现在送您60元福利红包，直接提现不套路~~~快来参与活动吧！\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","news_type":1},"isVote":1,"tweetType":1,"viewCount":339,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}